Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
67 studies found for:    Open Studies | "Skin Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Optical Tomographic Scanner for Skin Lesions
Condition: Skin Cancer, Benign Skin Tumor, Inflammatory Skin Disease
Intervention:
22 Not yet recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Conditions: Adenoid Cystic Carcinoma;   Adnexal Carcinoma;   Apocrine Carcinoma;   Eccrine Porocarcinoma;   Extraocular Cutaneous Sebaceous Carcinoma;   Hidradenocarcinoma;   Keratoacanthoma;   Malignant Sweat Gland Neoplasm;   Merkel Cell Carcinoma;   Microcystic Adnexal Carcinoma;   NK-Cell Lymphoma, Unclassifiable;   Non-Melanomatous Lesion;   Paget Disease;   Papillary Adenocarcinoma;   Primary Cutaneous Mucinous Carcinoma;   Refractory Anaplastic Large Cell Lymphoma;   Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma;   Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Refractory Mycosis Fungoides;   Refractory T-Cell Non-Hodgkin Lymphoma;   Sezary Syndrome;   Signet Ring Cell Carcinoma;   Skin Basal Cell Carcinoma;   Skin Basosquamous Cell Carcinoma;   Skin Squamous Cell Carcinoma;   Spiradenocarcinoma;   Squamous Cell Carcinoma of Unknown Primary Origin;   Stage III Skin Cancer;   Stage IV Skin Cancer;   Sweat Gland Carcinoma;   Trichilemmocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Talimogene Laherparepvec
23 Recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
24 Not yet recruiting Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Conditions: Actinic Keratosis;   Non-melanoma Skin Cancer
Intervention: Drug: aminolevulinic acid HCl
25 Not yet recruiting Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
Conditions: Melanoma and Other Malignant Neoplasms of Skin;   Metastatic Melanoma
Interventions: Drug: Azacitidine;   Drug: Pembrolizumab
26 Recruiting Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Conditions: Locally Advanced Basal Cell Carcinoma;   Skin Cancer;   Cutaneous Malignancy
Interventions: Drug: Vismodegib;   Radiation: Radiation therapy
27 Recruiting In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®
Conditions: Melanoma;   Head and Neck Cancer;   Sarcoma;   Non-Melanoma Skin Cancers
Intervention: Biological: Hiltonol
28 Not yet recruiting Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Conditions: Extensive Photodamage;   Actinic Keratosis;   History of Numerous Skin Cancers
Interventions: Device: Ultrapulse Carbon Dioxide Laser;   Device: Cellutome epidermal harvesting system
29 Not yet recruiting Negative Pressure Wound Therapy in Groin Dissection
Conditions: Neoplasm Metastasis;   Secondary Malignant Neoplasm of Lymph Node;   Non-healing Surgical Wound (Disorder);   Skin Neoplasms
Intervention: Device: PICO™
30 Recruiting Study of Skin Tumors in Tuberous Sclerosis
Conditions: Hereditary Neoplastic Syndrome;   Tuberous Sclerosis
Intervention:
31 Not yet recruiting Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
Conditions: Recurrent Skin Carcinoma;   Skin Squamous Cell Carcinoma
Intervention: Biological: Pembrolizumab
32 Recruiting Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Condition: Skin Basal Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Drug: Vismodegib
33 Recruiting Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Cockayne Syndrome;   Skin Cancer;   Xeroderma Pigmentosum;   Trichothiodystrophy;   Genodermatosis
Intervention:
34 Recruiting Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Conditions: Xeroderma Pigmentosum;   Melanoma;   Squamous Cell Carcinoma;   Basal Cell Carcinoma;   Skin Cancer
Intervention:
35 Recruiting Electronic Brachytherapy for the Treatment of NMSC
Conditions: Basal Cell Carcinoma;   Squamous Cell Carcinoma
Intervention: Radiation: electronic brachytherapy
36 Recruiting Reflectance Confocal Microscopy in Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Interventions: Device: Reflectance confocal microscopy;   Procedure: Punch biopsy;   Procedure: Surgical excision
37 Recruiting Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)
Conditions: Gastrointestinal Cancer;   Breast Cancer;   Gynecologic Cancer;   Genitourinary Cancer;   Leukemia;   Lung Cancer;   Skin Cancer;   Endocrine Cancer;   Male Genital Cancer
Intervention:
38 Recruiting Calcium Electroporation for Treatment of Cutaneous Metastases
Condition: Cutaneous Metastases
Interventions: Drug: Calcium electroporation;   Drug: Electrochemotherapy with bleomycin
39 Recruiting The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Conditions: Bladder Cancer;   Colorectal Cancer;   Endometrial Cancer;   Kidney Cancer;   Skin Cancer;   Uterus Cancer
Intervention: Behavioral: Health and Diet Questionnaire
40 Recruiting Spanish Registry of Mohs Surgery
Conditions: Skin Neoplasms;   Carcinoma, Basal Cell;   Carcinoma, Squamous Cell;   Dermatofibrosarcoma;   Melanoma;   Histiocytoma, Malignant Fibrous;   Neoplasms, Adnexal and Skin Appendage
Intervention: Procedure: Mohs surgery

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.